A detailed history of Fiducient Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Fiducient Advisors LLC holds 4,514 shares of ABBV stock, worth $812,520. This represents 0.1% of its overall portfolio holdings.

Number of Shares
4,514
Previous 4,445 1.55%
Holding current value
$812,520
Previous $762,000 16.93%
% of portfolio
0.1%
Previous 0.11%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$163.84 - $199.33 $11,304 - $13,753
69 Added 1.55%
4,514 $891,000
Q2 2024

Aug 06, 2024

SELL
$154.79 - $180.76 $528,607 - $617,295
-3,415 Reduced 43.45%
4,445 $762,000
Q1 2024

May 10, 2024

BUY
$159.82 - $182.1 $232,697 - $265,137
1,456 Added 22.74%
7,860 $1.43 Million
Q4 2023

Feb 05, 2024

BUY
$137.6 - $154.97 $159,616 - $179,765
1,160 Added 22.12%
6,404 $992,000
Q3 2023

Nov 03, 2023

BUY
$133.59 - $154.65 $700,545 - $810,984
5,244 New
5,244 $781,000
Q4 2022

Feb 03, 2023

BUY
$138.31 - $165.87 $6,500 - $7,795
47 Added 2.43%
1,980 $320,000
Q2 2022

Aug 04, 2022

SELL
$137.62 - $174.96 $15,963 - $20,295
-116 Reduced 5.66%
1,933 $296,000
Q1 2022

May 09, 2022

BUY
$131.98 - $163.75 $20,456 - $25,381
155 Added 8.18%
2,049 $332,000
Q4 2021

Feb 11, 2022

SELL
$107.43 - $135.93 $323,042 - $408,741
-3,007 Reduced 61.35%
1,894 $256,000
Q3 2021

Nov 03, 2021

SELL
$106.4 - $120.78 $21,280 - $24,156
-200 Reduced 3.92%
4,901 $529,000
Q2 2021

Aug 12, 2021

SELL
$105.21 - $117.21 $14,729 - $16,409
-140 Reduced 2.67%
5,101 $575,000
Q1 2021

May 14, 2021

BUY
$102.3 - $112.62 $14,322 - $15,766
140 Added 2.74%
5,241 $567,000
Q4 2020

Feb 11, 2021

BUY
$80.49 - $108.67 $410,579 - $554,325
5,101 New
5,101 $547,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Fiducient Advisors LLC Portfolio

Follow Fiducient Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiducient Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fiducient Advisors LLC with notifications on news.